Sermorelin
GHRH analog for sleep and vitality
$393 billed per 3-month shipment · cancel anytime
A gentler entry point into growth hormone support, often the first protocol prescribed for patients new to peptide therapy.
Final strength is set by your prescribing physician and may differ from your request.
Prescription required. A Vmed physician reviews your intake before anything is dispensed — you're not charged until approval.
Filled by a licensed 503A compounding pharmacy and shipped cold-chain.
What's included
- Nightly subcutaneous dosing
- Good first protocol for new patients
- Baseline labs reviewed before approval
- Easy step-up to CJC/Ipamorelin
Protocol details
- Route
- Subcutaneous injection
- Cadence
- Nightly
- Vial
- 9 mg or 15 mg lyophilized vial
- Dispensed by
- 503A compounding pharmacy
- Ships
- Cold-chain, 2-day, refrigerated
Clinical summary
A 29-amino-acid GHRH analog that stimulates the pituitary to release growth hormone in a natural pulsatile pattern.
Typical course: 3–6 months nightly, with IGF-1 recheck at 90 days.
Common side effects: Flushing, Injection-site swelling, Headache.
You may not be eligible if
- · Active malignancy
- · Pregnant or nursing
- · Untreated pituitary disorder
This is not medical advice. Your physician makes the final determination during review. Compounded medications are not FDA-approved.